AVANOS MEDICAL, INC. (AVNS) › Cash & EquivalentsAVANOS MEDICAL, INC. (AVNS) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2011: $20.10M2012: $47.90M2013: $44.10M2014: $149.00M2015: $129.50M2016: $113.70M2017: $219.70M2018: $384.50M2019: $205.30M2020: $111.50M2021: $118.50M2022: $127.70M2023: $87.70M2024: $107.70M2025: $89.80M$89.80M2011Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$89.80M-16.6%2024$107.70M+22.8%2023$87.70M-31.3%2022$127.70M+7.8%2021$118.50M+6.3%2020$111.50M-45.7%2019$205.30M-46.6%2018$384.50M+75.0%2017$219.70M+93.2%2016$113.70M-12.2%2015$129.50M-13.1%2014$149.00M+237.9%2013$44.10M-7.9%2012$47.90M+138.3%2011$20.10M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share